Clinical trial of a drug for nail infection.

Phase 2 clinical trial for assessment of safety and efficacy of a multi component botanical therapeutic (SKBRAM) in patients suffering from paronychia.

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2017/11/010625

Enrollment

250

Registered

2017-11-23

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Patients suffering from paronychia or nail infection

Interventions

Intervention1: SKBRAM: Dose: 5-6 drops Frequency: every hour Route of administration: Put drops on infected nail and allow to absorb from boundaries of nail. Duration: Minimum 15 days Control Interven

Eligibility

Inclusion criteria

Inclusion criteria: Patients suffering from paronychia or nail infection

Exclusion criteria

Exclusion criteria: Healthy human volunteers

Design outcomes

Primary

Measure	Time frame
Complete freedom from paronychia or nail infection such as no pus, no pain, no blood, no inflammation etc.Timepoint: 2 days	—

Secondary

Measure	Time frame
Complete freedom from paronychia or nail infection such as no pus, no pain, no blood, no inflammation etc.Timepoint: 15 days	—

Countries

India

Contacts

Public ContactAshok Kumar

SK Biotherapeutics Pvt. Ltd. (Previously SK Biolabs)

ashok846@gmail.com8126688922

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026